Prescribing biologics can require a complex approval and claims process. Creating a tiered system based on office workload can help practices understand and allocate staff time. Outsourcing approvals to pharmacies where possible can also streamline the process.
Dobkin underwent the procedure in order to connect with his patients considering it for themselves.
Cheri Frey, MD, discusses how emerging laser technologies are advancing melanocyte-sparing treatments while developing more precise targeting capabilities and enhanced safety features for diverse skin types.
Steve Feldman, MD, PhD, is part of an atopic dermatitis panel and focuses on strategies to hold pediatric patients and their parents accountable to treatment methods.
Scurto presented integrative medicine pearls at the 2024 Diversity in Dermatology meeting.
Pediatric melanoma, though rare, is the deadliest skin cancer in children, with 300-500 US cases annually.
Kamran H. Imam, MD, hopes to unlock insights into the atopic disease burden among Native American populations.
If granted, guselkumab will be approved to treat children ages 6 and younger with severe plaque psoriasis and children ages 5 and younger with juvenile psoriatic arthritis.
Lifestyle behaviors, such as body mass index and smoking, were shown to have a stronger association with psoriasis, regardless of genetic risk.
In part 4 of this Frontline Forum series, John M. Strasswimmer, MD, PhD; Andrew H. Weinstein, MD; Neal Bhatia, MD; Laura Ferris, MD; and Aaron S. Farberg, MD, discuss solutions for managing and treating patients with basal cell carcinoma.
A 5-expert panel continues their conversation on atopic dermatitis, discussing patient-centered care and key takeaways.
A patient returns to your clinic seeking systemic therapy for her AD while postpartum and breastfeeding. Test your knowledge on injectables.
Shawn Kwatra, MD, FAAD, reviews his late-breaking data presentation at AAD on the first original studies of a topical cream for prurigo nodularis.
Doctors cite more support staff, reduced patient panels among solutions.
Metz and Tollefson share insights on efficient practice management, work-life balance, and exciting developments in pediatric dermatology.
Eve Arnera and Thandiwe Munaiwa, MD, spoke about the groundbreaking collaboration between SkinCeuticals and ReSurge International, “Pioneering Women in Reconstructive Surgery.”
Phillips discusses Merz Aesthetics' recent research, which highlights how aesthetic treatments boost confidence, self-perception, and emotional well-being.
AI’s ability to quickly process and interpret large quantities of health data is a valuable tool for physicians.
In most kidney transplant recipients with advanced skin cancer, 2 checkpoint inhibitors are needed to boost the immune system, according to a new study.
Dermatologists Jeanine Downie, DiAnne Davis, and Hope Mitchell reveal the La Roche-Posay products they recommend to patients with dry skin, eczema, and more, at the flagship store in France.
Daniel Siegel, MD, shared strategies to manage surgery challenges, especially bleeding, to ensure a smooth experience for patients.
Survey responses revealed the rates and times at which patients switched from oral to biologic therapies.
Findings from a retrospective cohort study found that immune checkpoint inhibitors induced promising responses in the first- and second-line treatment of head and neck squamous cell carcinoma.
Expert insights on the latest issues in wounds as well as HS resources are shared at the annual meeting.
Jeffrey Yager, MD, discusses the new SY Aesthetics campus that will integrate traditional and Chinese healing.